NO During CPB in Neonates to Reduce Risk of AKI
Phase 3
40
about 3.5 years
0.00273790700698851–0.0848751172166437
1 site in OH
About this study
This trial is testing whether giving nitric oxide during cardiopulmonary bypass (CPB) can help prevent acute kidney injury (AKI) in newborns with congenital heart defects who are undergoing surgery. The goal is to see if this treatment reduces the risk of AKI after surgery.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Nitric Oxide
- 2.Take Oxygen
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
nitric oxide, oxygen
Secondary: Biomarker evidence of AKI - IL-18, Biomarker evidence of AKI - KIM-1, Biomarker evidence of AKI - L-FABP, Biomarker evidence of AKI - NGAL, Biomarker evidence of AKI - urinary nitrite
Cardiology / Heart